Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M. Marty, Cyrus Badshah, Per Ljungman et al.|New England Journal of Medicine|2017Cited by 1.2k
Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell TransplantsFrancisco M. Marty, Lindsey R. Baden, Lisa A. Cosimi|New England Journal of Medicine|2004Cited by 425
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Sophie Alain, Barbara D. Alexander et al.|Clinical Infectious Diseases|2021Cited by 299
Post-transplant acute limbic encephalitisWilliam W. Seeley, Edward B Bromfield, Francisco M. Marty et al.|Neurology|2007Cited by 280
Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative DisordersStanley I. Martin, Lindsey R. Baden, Francisco M. Marty et al.|Clinical Infectious Diseases|2006Cited by 270